IDL Biotech AB (XSAT:IDL) Short-Term Capital Lease Obligation : kr1.95 Mil (As of Jun. 2021)

View and export this data going back to 2004. Start your Free Trial

What is IDL Biotech AB Short-Term Capital Lease Obligation?

IDL Biotech AB's Short-Term Capital Lease Obligation for the quarter that ended in Jun. 2021 was kr1.95 Mil.

IDL Biotech AB's quarterly Short-Term Capital Lease Obligation increased from Dec. 2020 (kr1.93 Mil) to Mar. 2021 (kr1.94 Mil) and increased from Mar. 2021 (kr1.94 Mil) to Jun. 2021 (kr1.95 Mil).

IDL Biotech AB's annual Short-Term Capital Lease Obligation increased from Dec. 2018 (kr0.00 Mil) to Dec. 2019 (kr1.61 Mil) and increased from Dec. 2019 (kr1.61 Mil) to Dec. 2020 (kr1.93 Mil).

IDL Biotech AB Short-Term Capital Lease Obligation Historical Data

The historical data trend for IDL Biotech AB's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDL Biotech AB Short-Term Capital Lease Obligation Chart

IDL Biotech AB Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

1.61

1.93

IDL Biotech AB Quarterly Data
	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	-	1.93	1.94	1.95

IDL Biotech AB Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

IDL Biotech AB Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of IDL Biotech AB's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

IDL Biotech AB (XSAT:IDL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDL Biotech AB (XSAT:IDL) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Karlsbodavagen 39, Stockholm, SWE

Website

http://www.idl.se

IDL Biotech AB develops, produces and markets In Vitro Diagnostic tests for the health care sector. It offers in vitro diagnostic tests within the clinical areas of oncology and bacteriology. The company's trademark products includes TUBEX, TPS, UBC, MonoTotal and TPAcyk.

IDL Biotech AB (XSAT:IDL) Headlines

No Headlines